APA (7th ed.) Citation

M, H., RL, Z., A, B., D, D. G., V, J., M, V., . . . LM, B. (2026). Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: A machine learning analysis. Journal of cancer research and clinical oncology, 152(1), 34. https://doi.org/10.1007/s00432-025-06410-8

Chicago Style (17th ed.) Citation

M, Hoberger, et al. "Long-term Benefit from High-dose Ifosfamide in Sarcoma Depends on Sustained Prior Control and Timely Intervention: A Machine Learning Analysis." Journal of Cancer Research and Clinical Oncology 152, no. 1 (2026): 34. https://doi.org/10.1007/s00432-025-06410-8.

MLA (9th ed.) Citation

M, Hoberger, et al. "Long-term Benefit from High-dose Ifosfamide in Sarcoma Depends on Sustained Prior Control and Timely Intervention: A Machine Learning Analysis." Journal of Cancer Research and Clinical Oncology, vol. 152, no. 1, 2026, p. 34, https://doi.org/10.1007/s00432-025-06410-8.